LFMDLifeMD, Inc.

Nasdaq lifemd.com


$ 5.22 $ -0.31 (-5.63 %)    

Wednesday, 14-Aug-2024 15:59:57 EDT
QQQ $ 463.74 $ 0.15 (0.03 %)
DIA $ 400.12 $ 2.30 (0.58 %)
SPY $ 543.85 $ 1.71 (0.32 %)
TLT $ 97.88 $ 0.61 (0.63 %)
GLD $ 226.19 $ -1.86 (-0.82 %)
$ 5.2
$ 5.20 x 100
-- x --
-- - --
$ 3.46 - $ 12.88
458,607
na
214.74M
$ -1.47
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2024 06-30-2024 10-Q
2 05-08-2024 03-31-2024 10-Q
3 03-11-2024 12-31-2023 10-K
4 11-08-2023 09-30-2023 10-Q
5 08-09-2023 06-30-2023 10-Q
6 05-12-2023 03-31-2023 10-Q
7 03-22-2023 12-31-2022 10-K
8 11-10-2022 09-30-2022 10-Q
9 08-11-2022 06-30-2022 10-Q
10 05-13-2022 03-31-2022 10-Q
11 03-07-2022 12-31-2021 10-K
12 11-10-2021 09-30-2021 10-Q
13 08-13-2021 06-30-2021 10-Q
14 05-14-2021 03-31-2021 10-Q
15 03-30-2021 12-31-2020 10-K
16 11-16-2020 09-30-2020 10-Q
17 08-14-2020 06-30-2020 10-Q
18 05-19-2020 03-31-2020 10-Q
19 03-30-2020 12-31-2019 10-K
20 11-14-2019 09-30-2019 10-Q
21 08-14-2019 06-30-2019 10-Q
22 05-15-2019 03-31-2019 10-Q
23 04-01-2019 12-31-2018 10-K
24 11-14-2018 09-30-2018 10-Q
25 08-17-2018 06-30-2018 10-Q
26 05-15-2018 03-31-2018 10-Q
27 04-02-2018 12-31-2017 10-K
28 11-14-2017 09-30-2017 10-Q
29 08-14-2017 06-30-2017 10-Q
30 07-07-2017 03-31-2017 10-Q
31 05-24-2017 12-31-2016 10-K
32 11-14-2016 09-30-2016 10-Q
33 08-15-2016 06-30-2016 10-Q
34 05-16-2016 03-31-2016 10-Q
35 03-30-2016 12-31-2015 10-K
36 11-13-2015 09-30-2015 10-Q
37 08-13-2015 06-30-2015 10-Q
38 05-14-2015 03-31-2015 10-Q
39 03-30-2015 12-31-2014 10-K
40 11-14-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cantor-fitzgerald-reiterates-overweight-on-lifemd-maintains-15-price-target

Cantor Fitzgerald analyst Sarah James reiterates LifeMD (NASDAQ:LFMD) with a Overweight and maintains $15 price target.

 lifemd-q2-2024-adj-eps-006-beats-012-estimate-sales-50662m-beat-48251m-estimate

LifeMD (NASDAQ:LFMD) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $(0.12) by 150...

 keybanc-maintains-overweight-on-lifemd-lowers-price-target-to-10

Keybanc analyst Scott Schoenhaus maintains LifeMD (NASDAQ:LFMD) with a Overweight and lowers the price target from $12 to $10.

 lifemd-launches-commercial-health-insurance-acceptance-for-its-primary-care-services-including-weight-management

LifeMD, Inc. (NASDAQ:LFMD) today announced the launch of private health insurance acceptance for its virtual primary care servi...

 keybanc-initiates-coverage-on-lifemd-with-overweight-rating-announces-price-target-of-12

Keybanc analyst Scott Schoenhaus initiates coverage on LifeMD (NASDAQ:LFMD) with a Overweight rating and announces Price Tar...

 lifemd-files-prospectus-related-to-resale-from-time-to-time-of-up-to-13m-shares-of-common-stock-held-by-selling-stockholders

- SEC Filing

 lifemd-to-join-russell-3000-index
LifeMD To Join Russell 3000 Index
05/29/2024 12:06:13

 b-riley-securities-reiterates-buy-on-lifemd-maintains-12-price-target

B. Riley Securities analyst William Woods reiterates LifeMD (NASDAQ:LFMD) with a Buy and maintains $12 price target.

 hc-wainwright--co-reiterates-buy-on-lifemd-maintains-12-price-target

HC Wainwright & Co. analyst Yi Chen reiterates LifeMD (NASDAQ:LFMD) with a Buy and maintains $12 price target.

 cantor-fitzgerald-maintains-overweight-on-lifemd-raises-price-target-to-15

Cantor Fitzgerald analyst Sarah James maintains LifeMD (NASDAQ:LFMD) with a Overweight and raises the price target from $13 ...

 lifemd-q1-2024-adj-eps-001-beats-015-estimate-sales-44144m-beat-42540m-estimate

LifeMD (NASDAQ:LFMD) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.15) by 106...

 lifemd-becomes-the-first-virtual-primary-care-provider-to-elevate-glp-1-patient-care-with-real-time-at-home-monitoring-of-blood-pressure-and-body-composition

LifeMD, Inc.® (NASDAQ:LFMD), a leading provider of virtual primary care services, and Withings Health Solutions, a leader in di...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION